HerniaRepair near La Gurda Airport, NY

Biography: Dr. Alex Ky-Miyasaka, MD is a Colon /amp Rectal Surgery Specialist who practices in New York, NY. She is 59 years old and has been practicing for 31 years. Dr. Alex Ky-Miyasaka, MD is affiliated with Mount Sinai Queens and Mount Sinai Hospital.

Biography: Dr. Piotr Jerzy Gorecki is a graduate from Nicholas Copernicus Academy of Medicine at Jagiellonian University in Krakow, Poland, one of the oldest and most recognized medical schools and universities in Europe. Following his residency training at the New York Methodist Hospital, he completed Fellowship in Minimally Invasive Surgery at the Mayo Clinic. Serving as a Chief of Advanced Laparoscopy and Section Chief of Metabolic and Bariatric Surgery since 2001, he has introduced and developed a minimally invasive program for advanced GI/ Foregut, colorectal, solid organ and most notably the minimally invasive metabolic and bariatric surgery with accreditation at the American College of Surgeons / MBSAQIP as a Comprehensive Weight Loss Center with Adolescent Qualification.Clinical PracticeInspired by long-standing interest in Minimally Invasive Surgery (MIS) and followed by completion of MIS fellowship at the Mayo Clinic, my clinical activities and expertise have been focused around advancing laparoscopic techniques and minimally invasive approaches to disease of the foregut, solid organs, emergency laparoscopy and most noticeably laparoscopy for morbid obesity and obesity surgery for adolescents.Furthermore, our minimally invasive metabolic and bariatric practice was awarded as an ASMBS Bariatric Surgery Center of Excellence in 2005 (currently combined with American College of Surgeons (ACS) and with Adolescent Qualifications under ACS MBSAQIP / Quality Improvement Project. Our program has been one of the initial metabolic and bariatric centers of excellence in the tri-state area. Indeed, bariatric surgery for adolescents including long-term outcomes and modification of operative techniques has been my long-standing interest that resulted in establishing regional multidisciplinary metabolic and bariatric surgery center of excellence with adolescent designation.Moreover, system-based practice and value based surgical methods utilizing hand-sewn anastomotic techniques resulted not only in major cost savings to our institution but also in reduction of use of disposable instrumentation and reduction of medical waste, while further optimizing and enhancing highest quality patient care.To advance our clinical and research activities I have initiated, organized and maintained a prospectively collected bariatric database while maintaining busy clinical practice and surgical education to our surgical residents, medical students, PA students and GI fellows.Clinical LeadershipServing as a Chief of Advanced Laparoscopy and Section Chief of Metabolic and Bariatric Surgery since 2001, I have introduced and developed a minimally invasive program for advanced GI/ Foregut, colorectal, solid organ and most notably the minimally invasive metabolic and bariatric surgery with accreditation at the ACS MBSAQIP center.At the NYP Brooklyn Methodist Hospital, I have performed more than 3900 laparoscopic foregut and bariatric operations since the inception of the advanced MIS program in 2001 with the fortune of not experiencing any perioperative mortality and enjoying high patient satisfaction and an excellent safety profile for our clinical activities. These outcomes were reported at regional, national and international meetings (including SAGES, ASMBS, ACS, IFSO, DDW, NYSS, WCS) and more than 75 papers/abstracts were presented further contributing to the growing national and international recognition of our Metabolic and Bariatric Surgery Program at the NYP Brooklyn Methodist Hospital.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.

Biography: Russell S. Berman MD, Professor of Surgery at Weill Cornell Medicine, is a Surgical Oncologist who specializes in the treatment of patients with melanoma, non-melanoma cutaneous cancers, and sarcomas (soft tissue, retroperitoneal, and pelvic). He sees patients at both the Manhattan Upper East Side Campus as well as at NYP Brooklyn Campus. Administratively, Dr. Berman is the Associate Director for Clinical Education and the Associate Director for Surgical Oncology Network Integration for the Weill Cornell Medicine Sandra and Edward Meyer Cancer Center. A graduate of NYU Grossman School of Medicine, he performed his surgical training at NYU and Bellevue Hospitals. He completed a postdoctoral research fellowship at Memorial Sloan Kettering Cancer Center and a Surgical Oncology Fellowship at MD Anderson Cancer Center, where he also dedicated research time to investigating programmed cell death resistance during cancer progression. After training, Dr. Berman was recruited back to NYU. At NYU Dr. Berman was a tenured Professor of Surgery and served as Vice Chair for Surgical Education and Faculty Affairs, Chief of Surgical Oncology, and the long-standing Director of the Surgery Residency Program. A recipient of numerous teaching and graduate medical education awards, Dr. Berman has now been recruited to WCM to continue his passion for patient care, medical education (for students, trainees, and practicing clinicians) and growing multidisciplinary oncologic care and research programs.Dr. Berman's passion for cancer care and education/training extends to the national and international levels as well. At the national level, Dr. Berman recently served as Chair of the Complex General Surgical Oncology Board of the American Board of Surgery, where he was also chaired the American Board of Surgery (ABS) Nominating Committee and Certifying Examination Committee. He also was elected as Recorder of the ABS Council, having served as a Director and Councilor of the American Board of Surgery.Presently, Dr. Berman is President Elect (2025) of the Society of Surgical Oncology (SSO), the largest international organization of surgeons focused on care of the cancer patient. At the SSO he has also been held the positions of Vice President, Executive Council Member, Training Committee Chair, and Chair of the Education Council. Internationally, Dr. Berman is currently serving as the President of the Global Forum on Cancer Surgeons where he has co-authored the standard international curriculum in surgical oncology clinical training and the curriculum for oncologic research training. These training guidelines are currently being utilized by numerous countries in South America, Asia, and Africa.In 2022 Dr. Berman was elected as a member of the American College of Surgeons Academy of Master Surgeon Educators, an honor bestowed upon a select group of surgeons internationally. Additionally, Dr. Berman also serves on the ACGME Review Committee for Surgery, the oversight body for accrediting general surgery and complex general surgical oncology training programs in the United States. As a Melanoma Content Expert for the American College of Surgeons, he has co-authored standard melanoma operative procedure guidelines as well as operative reporting standards. As an author on over 200 peer-reviewed articles in the scientific literature, Dr. Berman also serves on the Editorial Boards of UpToDate, Surgical Oncology Insight and, the NCI Physicians Data Query. He recently completed terms on the Editorial Board of Annals of Surgical Oncology, as Associate Editor for the Journal of the National Cancer Institute, and as founding Chief Editor for the Complex General Surgical Oncology SCORE Training Portal for fellowship training and education. From the research perspective, Dr. Berman focuses on melanoma and surgical education. In addition to both clinical and translational research studies in melanoma, he has been involved in an active collaboration that investigates the care of solid tumor at safety net hospitals. From the surgical education research perspective, Dr. Berman co-authored the Professionalism in Surgical Training curriculum that became the basis for the national standard.

Biography: Juan Pablo Rocca, MD MHA is the Surgical Director for the Weill Cornell Liver Cancer Program, attending surgeon in the Division of Liver Transplantation and Hepatobiliary Surgery, Department of Surgery at New York-Presbyterian/Weill Cornell Medicine and Assistant Professor (Interim) of Surgery at Weill Cornell Medical College, Cornell University.Dr. Rocca has been practicing abdominal organ transplantation and hepatobiliary surgery in New York City since 2009, having prior appointments at the Recanati/Miller Transplantation Institute in the Mount Sinai Health System and at the Montefiore-Einstein Center for Transplantation in the Montefiore Health System. Devoted to surgical innovation, Dr. Rocca spearheaded the application of minimally invasive liver surgery at Montefiore Medical Center, employing both laparoscopic and robotic techniques for performing challenging oncologic operations in the liver affected by fibrosis and cirrhosis. Dr. Rocca has been also principal investigator in two multicenter research trials for the implementation of different novel machine perfusion devices for organ preservation in liver transplantation.Other remarkable past leadership positions in transplantation have been Surgical Director of the Living Donor Kidney program and Associate Director of the Transplant Surgery Fellowship program at Mount Sinai, Director of the Living Donor program and Surgical Director of the Kidney/Pancreas Transplantation program at Montefiore, Chair of the Membership and Workforce Committee of the American Society of Transplant Surgeons (ASTS), leading the latest Transplant Surgeons National Workforce Survey and Chair in the Clinical Policy Committee at the New York Center for Liver Transplantation (NYCLT). Dr. Rocca was awarded in 2018 by El Diario New York for his role and outreach within the Hispanic Community in the metropolitan area.Dr. Rocca earned his MD degree in 1999 at Universidad de Buenos Aires, completing a Residency in General Surgery in 2005 at Hospital Britanico de Buenos Aires, Universidad de Buenos Aires, Argentina. He continued his surgical training in the U.S. with a Transplant Surgery Fellowship at Westchester Medical Center, New York Medical College, followed by a second Transplant Surgery Fellowship at the Northwestern University Comprehensive Transplant Center in Chicago, completing his surgical training in 2009. Dr. Rocca also completed in 2019 an Executive Master in Health Administration (MHA) at the Mailman School of Public Health, Columbia University.

Biography: Mehraneh Dorna Jafari, MD, is Associate Professor of Surgery at Weill Cornell Medical College and Chief of Colorectal Surgery at NewYork-Presbyterian Brooklyn Methodist Hospital. She is the director of clinical research in the department of Surgery at Weill Cornell Medical Center. She is board-certified in general surgery and colon and rectal surgery. Dr. Jafari specializes in the comprehensive care of colorectal cancer patients, patients with peritoneal surface disease as well as those patients with benign colorectal disease.Dr Jafari works with a world-renowned group of multidisciplinary specialists to help promote a patient centered treatment plan for her patients, including radiation oncologists, medical oncologists, radiologists, pathologists, gastroenterologists, and interventional radiologists.Her goal is to provide precision medicine to patients that is safe and effective.Dr. Jafari has expertise in minimal access techniques, including laparoscopic, and robotic surgery. In addition, she has special interests in sphincter preserving surgery (helping rectal cancer patients avoid a permanent ostomy), maintaining fertility in cancer patients, and improving quality of life and bowel function after rectal surgery. Dr Jafari has been at forefront of research with regards to improving outcomes using enhanced recovery and narcotic sparing protocols.Dr. Jafari is among a small number of surgeons who offers surgery for metastatic colon, appendiceal and peritoneal surface disease. She utilizes cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC), which involves heated chemotherapy applied directly within the abdominal cavity following removal of cancerous tumors.Dr. Jafari's clinical research focuses on quality of life and oncological outcomes for colorectal cancer patients. Her main area of expertise is starting chemotherapy earlier in cancer treatment to allow patients to recover their quality of life sooner.Dr. Jafari has written extensively and published in many major journals, including the Journal of the American Medical Association (JAMA), Annals of Surgery, and the Journal of the American College of Surgeons. She has led numerable courses teaching surgeons around the country how to perform minimal invasive surgery.Dr. Jafari is actively involved in many national Surgical and Oncologic Societies, including the American College of Surgeons, Society of Surgical Oncologists, American Society of Colon and Rectal Surgeons and Association of Women Surgeons.Dr. Jafari completed her general surgical residency at University of California, Irvine and her Colorectal fellowship at NYP Weill Cornell/Columbia & Memorial Sloan Kettering Cancer Center. She then was appointed the as Director Education for the Department of Surgery and Associate program Director of Colon and Rectal Surgery at University of California, Irvine prior to joining Weill Cornell.